Source: International Congress 2015 – Phenotyping asthma with biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Aliae AR Mohamed-Hussein (Assiut, Egypt), Neveen Hassan, Aliae Mohamed-Hussein, Ebtssam Mohamed, Omnia Mohamed, Hanan Mohamed, Manal Tammam. Serum transforming growth factor –β1 (TGF-β1) in asthmatics: Association between disease control, severity and duration. Eur Respir J 2015; 46: Suppl. 59, 1465

Member's Comments

No comment yet.

Related content which might interest you: Association between cardio-ankle vascular index (CAVI) and chronic airway obstruction in asthma Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Role of protein phosphatase 5 (PP5) in mediating corticosteroid insensitivity in airway smooth muscle (ASM) cells in severe asthma Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Transforming growth factor alpha increases extracellular matrix within the airway smooth muscle layer in a transgenic mouse model of airway disease Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Circulating levels of IGF-I and IGFBP-3 in patients with COPD Source: International Congress 2015 – COPD: notable points Year: 2015 Altered P2 receptor expression profile in sputum cells of patients with COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Airway inflammation in patients with different levels of asthma control Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 miRNA-145 & SMAD3 expression in patients with COPD Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Mast cell gene signature enrichment associates with late-onset severe asthma Source: International Congress 2016 – Phenotyping asthma Year: 2016 Matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of metalloproteinase-1(TIMP-1) as non-invasive biomarkers of remodelling in asthma Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015 Relation between concentration of TNF-apha, IL-6, CRP and airway hyperresponsiveness in elderly asthmatics Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Reduced MicroRNA-19a causes constitutive high expression of PRMT1 and remodeling in asthma Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016 Coagulation activity increases with disease severity in patients with asthma Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Modulation of inflammation by benralizumab in eosinophilic airway disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Evaluation of inflammatory markers IL-6 and MMP-9 in asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Evaluation of the role of inflammation in chronic airways disease (ERICA): Midpoint evaluation Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 TH2 specific biomarker profile determines steroid responsiveness in severe asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013